Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Jefferies, Mizuho and Morgan Stanley top M&A financial advisers by value in South & Central America in H1 2025, Citi leads by volume, reveals GlobalData

Citi was the top mergers and acquisitions (M&A) financial adviser in the South & Central America region during the first half (H1) of 2025 by volume, while Jefferies, Mizuho Financial Group (Mizuho), and Morgan Stanley jointly occupied the top position by value, according to the latest financial advisers league table by GlobalData, which ranks financial […]
Read more

Kirkland & Ellis and Skadden, Arps, Slate, Meagher & Flom top M&A legal advisers in South & Central America in H1 2025, reveals GlobalData

Kirkland & Ellis and Skadden, Arps, Slate, Meagher & Flom were the top mergers and acquisitions (M&A) legal advisers in the South & Central American region during the first half (H1) of 2025 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, which ranks legal advisers by the value […]
Read more

European medtech companies to face uphill battle to maintain market shares from China’s import restrictions, says GlobalData

European medical device manufacturers are facing fresh pressure after China introduced new procurement limits on foreign-made equipment this month. The policy bars state hospitals and institutions from buying European devices in contracts exceeding 45 million yuan (roughly $6.3 million). This price range covers many of the most advanced tools used in hospitals. Medical giants such […]
Read more

FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharmaceutical approval landscape, says GlobalData

The US Food and Drug Administration (FDA) announced the approval of 127 innovator and biosimilar drugs in 2024, a notable decrease from the 149 approvals recorded in 2023. Despite the decline in overall approvals, the year saw a remarkable surge in innovative drug approvals, particularly from small pharmaceutical companies, many of which secured their first […]
Read more

Mazda’s advertising campaigns showcase innovation, performance, and environmental responsibility, reveals GlobalData

Mazda’s YouTube advertising campaigns for H1 2025 focused on innovation, performance, and community engagement. By showcasing a range of products, including the sporty MAZDA2 and the powerful CX-60, Mazda emphasizes its dedication to delivering exceptional driving experiences while fostering a sense of belonging among its customers. The Mazda SPIRIT RACING Driving Sunglasses highlight the brand’s […]
Read more

Argentina’s power capacity to increase to 61.8GW by 2035, forecasts GlobalData

Argentina has been grappling with significant power shortages in recent years, compelling the government to focus on augmenting the nation’s installed capacity. through the development of hydropower, nuclear power, and renewable energy. Against this backdrop, the cumulative power capacity of the country is forecast to reach 61.8GW in 2035, registering a compound annual growth rate […]
Read more

Subaru’s advertising campaigns focus on adventure, practicality and sustainability, reveals GlobalData

Subaru’s YouTube advertising campaigns for Q2 2025 highlight facets of exploration, sustainability, and practical solutions to target a diverse demographic. The cohesive strategy aims to address the interests of eco-conscious individuals and outdoor enthusiasts. The advertisements showcase models tailored for today’s drivers who value both high performance and responsible driving practices. By seamlessly integrating adventure […]
Read more

US tariff expansion on Chinese medical devices could significantly disrupt global supply chain, says GlobalData

Leading US medtech firms have mobilized on Capitol Hill to oppose proposed Section 301 tariffs on Chinese medical devices. Industry representatives, including AdvaMed, are urging lawmakers and trade officials to reconsider the tariff expansion amid growing concerns over its economic and clinical impact. The tariffs could significantly disrupt global supply chains and inflate healthcare costs, […]
Read more
1 … 35 36 37 38 39 … 136